Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD) June 16, 2024
Displaying entries 4476 - 4500 of 6046 in total
Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass ▼ Formula
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AR04
  • Cytolipin R(d18:1/22:0)
  • GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44261575 1310.843843 C66H122N2O23
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AT04
  • GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44261591 1310.843843 C66H122N2O23
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BF04
  • Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44261671 1310.843843 C66H122N2O23
Diacylglycerophosphoinositolglycans LMGP15010105
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-heptadecanoyl-2-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(17:0/16:0)
126457473 1310.699958 C60H111O28P
Diacylglycerophosphoinositolglycans LMGP15010128
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-nonadecanoyl-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(19:0/14:0)
126457496 1310.699958 C60H111O28P
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AA06
  • Fucalpha1-2Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44261857 1309.884979 C68H127NO22
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AZ06
  • Galalpha1-3(Fucalpha1-2)Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44261625 1309.884979 C68H127NO22
Diacylglycerophosphoinositolglycans LMGP15010106
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-heptadecanoyl-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(17:0/16:1(9Z))
126457474 1308.684308 C60H109O28P
Diacylglycerophosphoinositolglycans LMGP15010134
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-nonadecenoyl)-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(19:1(9Z)/14:0)
126457502 1308.684308 C60H109O28P
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AA08
  • Fucalpha1-2Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44261859 1307.869329 C68H125NO22
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AZ08
  • Galalpha1-3(Fucalpha1-2)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44261627 1307.869329 C68H125NO22
LMSL03001293
  • 2-O-octadecanoyl,3-O-(2S,4S,6S,8R,10R,12R,14R,16R-octamethyl)-17-hydroxy-tetratriacontanoyl)-2'-sulfotrehalose
  • AC2SGL(18:0/34:0(2Me[S],4Me[S],6Me[S],8Me[S],10Me[R],12Me[R],14Me[R],16Me[R],17OH))
126457734 1306.965477 C72H138O17S
Diacylglycerophosphoinositolglycans LMGP15010107
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-heptadecanoyl-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(17:0/16:2(9Z,12Z))
126457475 1306.668658 C60H107O28P
Diacylglycerophosphoinositolglycans LMGP15010140
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(19:2(9Z,12Z)/14:0)
126457508 1306.668658 C60H107O28P
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AL05
  • Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44260256 1297.848594 C66H123NO23
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AO05
  • Galbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44260280 1297.848594 C66H123NO23
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BD05
  • Galalpha1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44261656 1297.848594 C66H123NO23
Diacylglycerophosphoinositolglycans LMGP15010099
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1,2-dihexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(16:0/16:0)
126457467 1296.684308 C59H109O28P
Diacylglycerophosphoinositolglycans LMGP15010110
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-octadecanoyl-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(18:0/14:0)
126457478 1296.684308 C59H109O28P
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AL07
  • Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44260258 1295.832944 C66H121NO23
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AO07
  • Galbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44260282 1295.832944 C66H121NO23
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BD07
  • Galalpha1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44261658 1295.832944 C66H121NO23
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AN02
  • GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44260589 1295.807792 C64H117N3O23
Diacylglycerophosphoinositolglycans LMGP15010100
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-hexadecanoyl-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(16:0/16:1(9Z))
126457468 1294.668658 C59H107O28P
Diacylglycerophosphoinositolglycans LMGP15010116
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-octadecenoyl)-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(18:1(9Z)/14:0)
126457484 1294.668658 C59H107O28P

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024